Impact of 6-months of an advanced hybrid closed-loop system on sleep and psychosocial outcomes in youth with type 1 diabetes and their parents.
Autor: | Cobry EC; University of Colorado Anschutz Medical Campus, Barbara Davis Center for Diabetes, Aurora, CO, USA. Electronic address: erin.cobry@cuanschutz.edu., Pyle L; University of Colorado Anschutz Medical Campus, Barbara Davis Center for Diabetes, Aurora, CO, USA; Colorado School of Public Health, Department of Biostatistics and Informatics, Aurora, CO, USA., Karami AJ; University of Colorado Anschutz Medical Campus, Barbara Davis Center for Diabetes, Aurora, CO, USA., Sakamoto C; University of Colorado Anschutz Medical Campus, Barbara Davis Center for Diabetes, Aurora, CO, USA; Colorado School of Public Health, Department of Biostatistics and Informatics, Aurora, CO, USA., Meltzer LJ; National Jewish Health, Denver, CO, USA; Nyxeos Consulting, Denver, CO, USA., Jost E; University of Colorado Anschutz Medical Campus, Barbara Davis Center for Diabetes, Aurora, CO, USA., Towers L; University of Colorado Anschutz Medical Campus, Barbara Davis Center for Diabetes, Aurora, CO, USA., Paul Wadwa R; University of Colorado Anschutz Medical Campus, Barbara Davis Center for Diabetes, Aurora, CO, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | Diabetes research and clinical practice [Diabetes Res Clin Pract] 2024 Jan; Vol. 207, pp. 111087. Date of Electronic Publication: 2024 Jan 03. |
DOI: | 10.1016/j.diabres.2023.111087 |
Abstrakt: | Introduction: Youth with type 1 diabetes (T1D) and parents experience reduced quality of life and sleep quality due to nocturnal monitoring, hypoglycemia fear, and diabetes-related disruptions. This study examined the sleep and quality of life impact of advanced technology. Methods: Thirty-nine youth with T1D, aged 2-17 years, starting an advanced hybrid closed-loop (HCL) system and a parent participated in an observational study. Surveys, actigraphy, sleep diaries, and glycemic data (youth) were captured prior to HCL, at one week, 3 months, and 6 months. Outcomes were modeled using linear mixed effects models with random intercepts to account for within-subject correlation, with least-squares means at each timepoint compared to baseline. Results: Parents and youth reported improvements in health-related quality of life and fear of hypoglycemia after HCL initiation. Concurrently, nocturnal glycemia improved. Actigraphy-derived sleep outcomes showed improved 6 month adolescent efficiency and 3 and 6 month parent wake after sleep onset. Additionally, parents reported improved subjective sleep quality and child sleep-related impairment at 3 months. Conclusions: With nocturnal glycemic improvements in youth using HCL technology, some aspects of parent and youth sleep and quality of life improved. This may reflect decreased parental monitoring and worry and highlights benefits for youth beyond glycemia. Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (Copyright © 2024 Elsevier B.V. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |